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Objectives: At the completion of this presentation, you 
should be able to:
1. Describe the roles of the medical consultant in perioperative 
consultation
2. Name and apply principles of risk stratification for patients 
who are undergoing non-cardiac surgery
3. Assist procedural specialists in assessing perioperative risk in 
medical patients undergoing non-cardiac surgery
Evidence Sources: 
ACC/AHA 2014 Guidelines on Perioperative Cardiovascular
Evaluation and Care for Non-cardiac Surgery, updated
A Report of the American College of Cardiology

































No additional studies 
needed
Procedure/Treatmen
t should NOT be 
performed/administe
red SINCE IT IS 
NOT HELPFUL 
AND MAY BE 
HARMFUL
American College of Cardiology: Applying Classification of 
Recommendations and Level of Evidence 
Questions about surgery
• What are your roles as the consultant/advisor to the 
surgeon?
• What are the risks?  Sources of risk?
• How do you assess & communicate the risks?





• Sharing your assessment & 
determination of risk with the 
patient
• Exhaustive H & P
• “Rambling” recommendations
• Relying solely on chart 
documentation
• Quick sign off, when co-
management is requested
DO
• “Is an acceptable risk”
• Reporting & discussing your 
findings with the requesting 
surgeon
• Be thorough but focus on what 
matters for the surgery
• “Definitive, prioritized and 
precise” recommendations
• Pick up the phone, speak directly 
with surgical team
• Follow up & continue to monitor 
for changes
(Source: Up to Date)
The History of Risk Factor Prediction in 
Non Cardiac Surgery
• NEJM (1977)
• The value of resident 
research
• “Goldman criteria”
• Revised Cardiac Risk Index
Lee Goldman, MD
The Original Goldman Criteria
Criteria (Risk) Points
S3 gallop or JVD on exam (active CHF) 11
MI in previous 6 months 10
PVC's> than 5/min at any time before 
operation  #
7
Rhythm other than sinus or PAC's on last 
ECG  #
7
Age > than 70 5
Emergency operation 4
Poor general health (PaO2 < 60, PaCO2 > 50, 
K + <3, HCO3 < 20, BUN > 50, Cr > 3, 
elevated transaminases, signs of chronic 
liver disease or patient bedridden from non-
cardiac causes)
3
Important valvular aortic stensois 3
Intraperitoneal, intrathoracic, or aortic 
surgery
3
(NEJM 1977;297:845-850)(Note # :  Only counted if underlying CV disease present)
Validation and cardiac risk stratification for 
Goldman’s criteria leading to 
the Revised Cardiac Risk Index 
Risk for Life Threatening Cardiac 
Complication Or Death
Class Point Total Combined 
Incidence
Range
I 0-5 1.6% 1-7%
II 6-12 5% 3-11%
III 12-25 16% 14-38%
IV 25-53 56% 30-100%
(Lee, et al, NEJM 1977;297:845-850)
Revised Cardiac Risk Index (RCRI) 
1.History of CHF
2.History of ischemic heart disease 
• (history of MI or a positive exercise test, current complaint of chest pain 
considered to be secondary to myocardial ischemia, use of nitrate therapy, 
or ECG with pathological Q waves; do not count prior coronary 
revascularization procedure unless one of the other criteria for ischemic 
heart disease is present)
3.Vascular type of surgery (includes any intraperitoneal, 
intrathoracic, or suprainguinal vascular procedures)
4.Preoperative serum creatinine >2.0 mg/dL
5.Diabetes mellitus requiring treatment with insulin
6.History of cerebrovascular disease 
Rates of death, non-fatal MI & non-fatal cardiac 
arrest, based on  Revised Cardiac Risk Index
• 0 risk factors =  0.4 percent 
(95% CI 0.1-0.8 percent)
• 1 risk factor = 1.0 percent 
(95% CI 0.5-1.4 percent)
• 2 risk factors =  2.4 percent 
(95% CI 1.3-3.5 percent)
• 3 or more risk factors - 5.4 percent 
(95% CI 2.8-7.9 percent)
(Deveraux et al., CMAJ 2005)
Summary: Sources of risk for the 
patient facing surgery
Related to the surgery
• Emergent surgery = higher risk
• Vascular  surgery = higher risk
Related to the patient
• Active Cardiac Conditions
• Clinical factors (RGCI)
• Functional capacity of the patient: based on activity 
level in METs
Mr. Vandermeer
A 71 y.o. male, is sent to you by his orthopedic surgeon for pre-operative 
assessment prior to elective hip replacement surgery. 
• His problem list includes a history of: HTN, type II DM Obesity 
(BMI=30), high cholesterol, DJD of his knees and hips and CKD, 
stage III (sCr=1.6, GFR=55). 
• One hospital admission 6 years ago for accelerated HTN, 
complicated by mild heart failure. Since then, he has seen you 
regularly for HTN management, and his BP’s have been well 
controlled.  He has not had any episodes of heart failure since. 
• Surgical hx:  T & A as a child, hernia repair 20 years ago.
• SH: Smokes 5-7 cigarettes a day.  ETOH: 1-2 beers on a weekend
Mr. V: (cont’d)
• Meds: Lisinopril/Hctz 20/25 mg 1daily, Metoprolol succinate (Toprol XL) 50 
mg qD, Metformin 1000 mg BID, glipizide 5 mg BID, meloxicam 15 mg daily, 
ASA 81 mg daily; simvistatin 20 mg daily
• ROS: CV-denies any CP, SOB, orthopnea; he does get winded walking up >1 
flight of steps or walking uphill with no recent change in symptoms and no 
angina ; MSK--activity is limited by hip pain; EXT—no edema; no weight gain 
recently
• Data review: 
• Echocardiogram 9 months ago which showed an EF =55%, mild LVH, 
impaired diastolic relaxation, mild MR.
• Glucose is 140; LDL =145; HgbA1C = 7.2
Physical Exam is unremarkable except for:
VS: BMI =30; BP = 156/95; P=72
Overweight w male.
Heart: Regular rhythm, Gr 1/6 mid systolic 
murmur at the LSB
Ext: no edema, peripheral pulses are 
+1 posterior tib., tr/4 dorsalis pedis bilaterally
Monofilament exam shows reduced sensation
EKG
Thomas Snyder           DOB: 4/23/50Thomas Snyder           DOB: 4/23/50
Mr. V’s EKG
NSR, 62 bpm. Normal axis, J point elevation in I and AvL, 
no ST-T changes. Voltage criteria for LVH. 
You recommend to Mr. V that he…
A) Proceed with the planned procedure
B) Have further testing which will allow you to 
better assess his risk for medical complications
C) Cancel his surgery as it would be too dangerous
D) Should contact his attorney to “put his affairs 
in order”
Mr V: What more do we need to know 
for him to proceed safely?
•What additional history you would like?
• Anything on exam that would demand your attention or 
influence your decision-making right up front?
•Would you order any additional studies?  
•What criteria will you use to estimate his surgical risk?
Let’s assess Mr. V’s risk, using the ACC step-wise 
approach 
(Source:  ACC Guidelines, 2007)
Risk assessment: A step-wise approach
1. Urgent or emergent surgery?
• Mortality rates were 5% at 30 days, 12% after 
1 year--Compare with Goldman rates of 1-5%
• The high initial death rate continued for 
about 100 days after surgery. 
(Neary, Annals of the Royal College of Surgeons of England, 
2006: vol. 88, no2, pp. 151-156)
Risk assessment: Step 2
Are there any “active cardiac  conditions”?
• Active CONGESTIVE HEART FAILURE
• Significant ARRYTHMIAS 
• Lousy VALVES
• ISCHEMIA 




Active Cardiac Conditions for Which the Patient Should Undergo Evaluation 




§ Unstable or severe angina* (CCS class III or IV)†
§ Recent MI‡
Decompensated HF  * § NYHA functional class IV; 
§ Worsening or new-onset HF
Significant arrhythmias
( * = were part of the original
Goldman criteria) 
Note: simple VPC’s &
APC’s not on this list
§ High-grade atrioventricular block
§ Mobitz II atrioventricular block
§ Third-degree atrioventricular heart block
§ Symptomatic ventricular arrhythmias
§ Supraventricular arrhythmias (including atrial fibrillation) with 
uncontrolled ventricular rate (HR > 100 bpm at rest)
§ Symptomatic bradycardia
§ Newly recognized ventricular tachycardia
Severe valvular disease § Severe aortic stenosis (mean pressure gradient greater than 40 
mm Hg, aortic valve area less than 1.0 cm2, or symptomatic)
§ Symptomatic mitral stenosis (progressive dyspnea on exertion, 
exertional presyncope, or HF)
CCS indicates Canadian Cardiovascular Society; HF, heart failure; HR, heart rate; MI, myocardial infarction; NYHA, 
New York Heart Association. *According to Campeau.10 †May include stable angina in patients who are unusually 
sedentary. ‡The ACC National Database Library defines recent MI as more than 7 days but  within 30 days)
Risk assessment: A step-wise approach
3.Risk related to type of surgery
• What procedure is Mr. V having?
Cardiac Risk Stratification for Non Cardiac Surgical 
Procedures
• High (Cardiac risk > 5%): emergent major operations, aortic and 
other vascular, peripheral vascular, prolonged surgical procedure 
with associated with large fluid shifts or blood loss
• Intermediate (Cardiac risk 1-5%): Carotid endarterectomy, 
intraperitoneal and intrathoracic surgery, head and neck, 
orthopedic and prostate
• Low (Cardiac risk < 1%): endoscopic procedures, superficial 
procedures, cataract, breast 
Risk assessment: A step-wise approach
4.Functional Capacity: 
• Based on activity level, capability to physical exertion (as 
estimated in METs)
• Mr V: + DOE with >1 flight of steps and with walking up a hill
Estimated Energy Requirements for Various Activities
Can You… Can You…
1 Met Take care of yourself? 4 Mets Climb a flight of stairs or walk 
up a hill?
Eat, dress, or use the toilet? Walk on level ground at 4 mph 
(6.4 kph)?
Walk indoors around the 
house?
Do heavy work around the house 
like scrubbing floors or lifting or 
moving heavy furniture?
Walk a block or 2 on level 
ground at 2 to 3 mph (3.2 to 
4.8 kph)?
Participate in moderate 
recreational activities like golf, 
bowling, dancing, doubles 
tennis, or throwing a baseball or 
football?
4 Mets Do light work around the 




Participate in strenuous sports 
like swimming, singles tennis, 
football, basketball, or skiing?
MET indicates metabolic equivalent; mph, miles per hour; kph, kilometers per hour. *Modified from Hlatky et al,11 
copyright 1989, with permission from Elsevier, and adapted from Fletcher et al.12

Now, let’s reassess Mr. V’s risk
(Source:  ACC Guidelines, 2007)
Cardiac evaluation and care algorithm for non-cardiac surgery
Good functional 
capacity (>4 METS) 
without symptoms
Step 4
Consider non invasive testing,  if it will change treatment (Class 2 b, LOE=B)
Risk assessment: A step-wise approach
5.Counting clinical risk factors
• “CHARDS” (Revised Cardiac Risk Index): most important—
what are they?
• CHF, “Angina” (active ischemia), Renal, Diabetes, Stroke + 
Intermediate risk surgery (supra-inguinal, abdominal, thoracic)
• Other (“minor”) risk factors: 
• Advanced age  (>70)
• Abnormal ECG
• Rhythm other than sinus
• Uncontrolled systemic hypertension 
• What traditional cardiac risk factor is noticeably absent?
Mr. Vandermeer’s risk summary
71 y.o. male sent to you by his orthopedic surgeon for pre-operative 
assessment prior to elective hip replacement surgery. 
• His problem list includes a history of: HTN, type II DM Obesity (BMI=30), 
high cholesterol, DJD of his knees and hips and CKD, stage III (sCr=1.6, 
GFR=55). Knee pain limits physical activity to < 4 METS
• One hospital admission 6 years ago for accelerated HTN, complicated by 
mild heart failure. Regular follow up since then, & his BP’s have been well 
controlled.  He has not had any episodes of heart failure since. 
• Echocardiogram 9 months ago showed an EF =55%, mild LVH, impaired 
diastolic relaxation, mild MR.
• SH: Smokes 5-7 cigarettes a day.  ETOH: 1-2 beers on a weekend
Proceed to surgery?  
Mr.V: What testing should he have?
• Another ECHO?
• A stress test?  If so, which type?
Recommendations for Preoperative Noninvasive 
Evaluation of LV Function
• Class I (none)
• Class IIa
• It is reasonable for patients with dyspnea of unknown origin to undergo 
preoperative evaluation of LV function. (C)
• It is reasonable for patients with current or prior HF with worsening 
dyspnea or other change in clinical status to undergo preoperative 
evaluation of LV function if not performed within 12 months. (C)
• Class IIb
• Reassessment of LV function in clinically stable patients with previously 
documented cardiomyopathy is not well established. (C)
• Class III
• Routine perioperative evaluation of LV function in patients is not 
recommended. (B)
Recommendations for Noninvasive Stress 
Testing Before Non-cardiac Surgery
• Class I: Patients with active cardiac conditions in whom non-cardiac surgery is planned 
should be evaluated and treated per ACC/AHA guidelines before non-cardiac surgery. (B)
• Class IIa: Noninvasive stress testing of patients with 3 or more clinical risk factors and poor 
functional capacity (less than 4 METs) who require vascular surgery is reasonable if it will 
change management. (B)
• Class IIb: Noninvasive stress testing may be considered for patients:
• With at least 1 to 2 clinical risk factors and poor functional capacity (less than 4 
METs) who require intermediate-risk non-cardiac surgery if it will change 
management. (B)
• With at least 1 to 2 clinical risk factors and good functional capacity (greater than or 
equal to 4 METs) who are undergoing vascular surgery. (B)
• Class III: Noninvasive testing is not useful for patients: 
• With no clinical risk factors undergoing intermediate-risk noncardiac surgery. (C)
• Undergoing low-risk noncardiac surgery. (C)
Mr V. had…. 
A pharmacologic, nuclear stress test which was negative for ischemia with a 
hypertensive BP response, estimated ejection fraction of 55%
• Noninvasive testing has a negative predictive value of almost 100 percent for perioperative 
death or nonfatal MI but a positive predictive value of less than 20 percent (eg, 98 and 18 
percent, respectively in a review of five studies of dipyridamole-thallium imaging.  ( Up to Date, 
2009)
• Is he “an acceptable risk” for the planned procedure?  
• Do you have any suggestions for the surgeon for his perioperative 
management?
• What about his BP (156/95)?   
• He’s on lisinopril/hctz 20/25 mg, metoprolol succinate 50 mg
Other risk stratification models   (See Qx Calculate by QxMD)
American College of Surgeons NSQIP Gupta perioperative Cardiac Risk
American Society of Anesthesiologists Geriatric Sensitive Periop Risk Index
Summary
Estimate & communicate the patient’s risk
• Type of surgery: emergent or vascular = higher risk
• Active cardiac problems = higher risk
• Surgical procedure risk: low, intermediate, high
• Functional capacity of the patient,  based on activity level (<4 
METS = higher risk)
• If intermediate surgical procedure and poor functional capacity, 
assess patient clinical factors (Revised Cardiac Risk Index = 
“CHARDS”) and test if result will influence management
Summary of Approach 
• Patients at low risk : generally require no further evaluation before 
surgery, as long as
• No active cardiac conditions
• Low risk surgery
• Patients at high risk (eg, vascular surgery in other than low risk patients, 
signs or symptoms of severe or unstable coronary disease) usually undergo 
additional evaluation by cardiologists
• Patients at intermediate risk represent a heterogeneous group that 
includes those at low and high risk. The use of noninvasive testing can be 





• As a consultant, you use the same inpatient or outpatient E & M 
codes that you would if you were providing the care 
• Office consultations:99202-99205 (new), 99212-99215 
(established)
• PF, EPF, Detailed w/mod complexity, Comp. w/ high complexity
• Inpatient consultations: 99221-99223 (if new), 99231-99233 (if 
established)
• Comprehensive with low, mod, high complexity
• Including the name, specialty of the doctor who has requested 
the consult may help your staff
A Few Words about Beta-blockers 
• The 2007 ACC guidelines favored using beta-blockers in 
patients who have a history of ischemic heart disease or stable 
angina
• Rationale: B-blockers reduce workload of the heart, prevent angina in 
susceptible individuals
• Since then, evidence has emerged that has required a re-
thinking of this strategy
Perioperative beta blockers: 
Meta-analysis (2008)
• 33 trials, 12,306 patients
• No significant reduction in all cause mortality, cardiovascular 
mortality, heart failure
• Decrease in non-fatal MI (NNT=63) and myocardial ischemia 
(NNT=16) at the expense of:
• Increased risk of non-fatal strokes (NNH=293)
• B-blockers associated with high risk of perioperative
• Bradycardia requiring treatment (NNH=22)
• Hypotension (NNH=17)
(Bangalore et al, Lancet, 2008 Nov 11; 372: 1962-1976)
Peri-operative beta-blockers: Take home points
• “Routine administration of high-dose beta blockers in the 
absence of dose titration is not useful and may be harmful to 
beta-blocker-naive patients undergoing surgery." (ACC/AHA, 2009 
Update)
• OK to continue in those who have been on them for several 
weeks, as part of their regular regimen. 
• They do not have to be discontinued, provided that the patient has not 
had problems with orthostatic hypotension, symptomatic bradycardia or 
high grade cardiac conduction problems
ACC/AHA 2009 Update on B-blockers 
in vascular surgery 
• Beta blockers are reasonable to consider in:
• patients at high risk for heart attacks or other cardiac complications because of 
abnormal stress test results or known coronary artery disease who undergo vascular 
surgery (IIa, C)
• Careful titration to BP and HR necessary
• high-risk patients undergoing intermediate risk surgery or in those with multiple risk 
factors for complications, such as diabetes, a history of heart failure or significant 
kidney disease, who undergo vascular surgery (IIb, C)
• Hot area for research, discussion
• Stayed tuned, keep reading
Pulmonary Risk Factors
• Age >50 years 
• Chronic obstructive lung disease 
• Congestive heart failure 
• Poor general health status as defined by ASA class >2 
• Functional dependence 
• Serum albumin <35 gm/L 
• Upper abdominal, thoracic, aortic, head and neck, neurosurgery, and 
abdominal aortic aneurysm surgery 
• Surgery lasting greater than three hours 
• Emergency surgery 
• Use of pancuronium as a neuromuscular blocker
(Source:  Up to Date, 2009, based on several studies cited within)
Maximizing Pulmonary Function Pre-operatively
• Smoking cessation for eight weeks 
• Inhaled anticholingic for all patients with clinically significant 
COPD 
• Inhaled beta-agonists for patients with COPD or asthma who 
have wheezes or dyspnea 
• Preoperative glucocorticoids for patients with COPD or asthma 
who are not optimized and whose airway obstruction has not 
been maximally reduced 
• Delay elective surgery if respiratory infection present 
• Antibiotics for patients with infected sputum 
• Preoperative inspiratory muscle training 
(Source: Up to Date, 2009)
ACC 
Guideline
Algorithm
First steps
Assuming 
Non emergent
& 
No ACS
Next Steps
